Aziyo Biologics is Biotechnology in United States that focus on Aziyo Biologics Inc business. Founded in 2015. They cover business area such as Aziyo Biologics Inc, differentiated product, outcome, patient, surgery, implantable medical device, unmet clinical need, healthy tissue formation, complication, medical device implant, scar-tissue formation, capsular contraction, erosion, migration, non, union, implant rejection.
2015
( 9 years old in 2024 )
Aziyo Biologics Inc
-
12510 Prosperity Drive
Suite 370
Silver Spring, MD 20904
United States
Private
Aziyo Biologics Incdifferentiated productoutcomepatientsurgeryimplantable medical deviceunmet clinical needhealthy tissue formationcomplicationmedical device implantscar-tissue formationcapsular contractionerosionmigrationnonunionimplant rejection
* We use standard office opening hours in near Aziyo Biologics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Aziyo Biologics is Biotechnology business from United States that founded in 2015 (9 years old in 2024), Aziyo Biologics business is focusing on Aziyo Biologics Inc.
Aziyo Biologics headquarter office and corporate office address is located in 12510 Prosperity Drive Suite 370 Silver Spring, MD 20904 United States.
Aziyo Biologics was founded in United States.
In 2024, Aziyo Biologics is currently focus on Aziyo Biologics Inc sector.
Above is snippet of Google Trends for "Aziyo Biologics Inc" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Aziyo Biologics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
